Frédéric Peyrade
Centre Hospitalier de Cannes(FR)Centre Antoine Lacassagne(FR)
Publications by Year
Research Areas
Lymphoma Diagnosis and Treatment, CNS Lymphoma Diagnosis and Treatment, Statistical Methods in Clinical Trials, Cancer Immunotherapy and Biomarkers, Pancreatic and Hepatic Oncology Research
Most-Cited Works
- → Radiotherapy or Autologous Stem-Cell Transplantation for Primary CNS Lymphoma in Patients Age 60 Years and Younger: Long-Term Results of the Randomized Phase II PRECIS Study(2022)94 cited
- → Subcutaneous Rituximab-MiniCHOP Compared With Subcutaneous Rituximab-MiniCHOP Plus Lenalidomide in Diffuse Large B-Cell Lymphoma for Patients Age 80 Years or Older(2021)71 cited
- → Germinal Immunogenetics predict treatment outcome for PD-1/PD-L1 checkpoint inhibitors(2019)53 cited
- → Hyperprogression under Immune Checkpoint Inhibitor: a potential role for germinal immunogenetics(2020)36 cited
- → Molecular Targeted Therapies in the Management of Head and Neck Squamous Cell Carcinoma: Recent Developments and Perspectives(2013)19 cited
- → Physiopathologie et prise en charge des ascites malignes réfractaires(2011)18 cited
- → Cabazitaxel in recurrent/metastatic squamous cell carcinoma of the head and neck: phase II UNICANCER trial ORL03(2017)3 cited
- → Amifostine Can Reduce Oral Mucositis after High-Dose Melphalan Conditioning in Patients with Multiple Myeloma: A Retrospective Study.(2004)2 cited
- → Synthetic control arm from mixed clinical trials and real-world data from the LYSA group for untreated diffuse large B-cell lymphoma patients aged over 80 years: a bona fide strategy for innovative clinical trials(2025)2 cited
- → Early positron emission tomography response-adapted treatment in low-risk diffuse large B-cell lymphoma: an open-label, multicenter, randomized, noninferiority phase III trial(2025)1 cited